Search - tctmd.com

Displaying 281 - 300 of 2728

Sort: Relevancy | Date

News Conference News AHA 2024

ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH

Caitlin E. Cox

November 18, 2024

News Conference News AHA 2024

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Michael O'Riordan

November 16, 2024

News Conference News AHA 2024

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

Shelley Wood

November 16, 2024

News Conference News AHA 2024

Intensive BP Lowering in Diabetes Reduces CV Events: BPROAD

Yael L. Maxwell

November 16, 2024

News Daily News

Hypertensive Disorders of Pregnancy Lead to Earlier, More Severe CAD

Caitlin E. Cox

November 12, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Daily News

Machismo in Youth Linked to Fewer CVD Diagnoses, Less Treatment in Adulthood

Caitlin E. Cox

November 06, 2024

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

Presentation TCT 2024

TCT 1583: Successful Multidisciplinary Management of Late Presentation of HOCM With Severe Pumonary Hypertension With Multiple Interventional Techniques

Presenter: Sukhdeep Basra

October 30, 2024

Presentation TCT 2024

TCT 817: Impact of Pulmonary Hypertension on Outcomes of PCI in Acute Myocardial Infarction: A Contemporary 5-Year Nationwide Analysis

Presenter: Viet Nghi Tran

October 29, 2024

Presentation TCT 2024

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Presenter: Raymond Townsend

October 29, 2024

Presentation TCT 2024

Debate Con: RDN Will Ultimately Be a Niche Therapy

Presenter: Andrew Sharp

October 29, 2024

Presentation TCT 2024

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

Presenter: Michael Weber

October 29, 2024

Presentation TCT 2024

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

Presenter: Michael Bloch

October 29, 2024

Presentation TCT 2024

What Evaluation is Required for Patient Selection for RDN?

Presenter: Naomi Fisher

October 29, 2024

Presentation TCT 2024

Case 2: TTVI in Pulmonary Hypertension – Where Do We Draw the Line for Interventional Treatment?

Presenter: Laura Davidson

October 29, 2024

Presentation TCT 2024

What’s Next - Going into 2025

Presenter: Vijay Iyer

October 28, 2024

Advertisement

ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

Intensive BP Lowering in Diabetes Reduces CV Events: BPROAD

Hypertensive Disorders of Pregnancy Lead to Earlier, More Severe CAD

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

Machismo in Youth Linked to Fewer CVD Diagnoses, Less Treatment in Adulthood

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

TCT 1583: Successful Multidisciplinary Management of Late Presentation of HOCM With Severe Pumonary Hypertension With Multiple Interventional Techniques

TCT 817: Impact of Pulmonary Hypertension on Outcomes of PCI in Acute Myocardial Infarction: A Contemporary 5-Year Nationwide Analysis

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Debate Con: RDN Will Ultimately Be a Niche Therapy

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

What Evaluation is Required for Patient Selection for RDN?

Case 2: TTVI in Pulmonary Hypertension – Where Do We Draw the Line for Interventional Treatment?

What’s Next - Going into 2025

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content